Alliance A151216 (Lung Cancer) - Clinical Trial

What is the Purpose of this Study?


We are doing this study to research the genes of patients with lung cancer that has been or will be removed by surgery for a chance to get treatment in a clinical trial.

What is the Condition Being Studied?

Genetic testing for patients with lung cancer that has been removed or can be removed by surgery

Who Can Participate in the Study?

Key Eligibility

Adults 18 years and older who:
- Have lung cancer that has been removed by surgery or can be removed by surgery
- Have not received chemotherapy or radiation before surgery
- Are not pregnant
- Do not have recurrent lung cancer

Age Group

What is Involved?


If you choose to join this study, you will:
- Answer questionnaires
- Have blood draws
- Have tissue samples taken
- Possibly be eligible to join another clinical trial, depending on the results of your genetic testing
- Be contacted by the study team every 6 months for 5 years

Study Details

Full Title
Alliance A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Principal Investigator
Medical Oncologist
Protocol Number
IRB: PRO00057971
NCT: NCT02194738
Phase N/A
Enrollment Status
Open for Enrollment